Article Text

Download PDFPDF
Short term cyclosporin A treatment of Behçet's disease.
  1. A U Müftüoğlu,
  2. H Pazarli,
  3. S Yurdakul,
  4. H Yazici,
  5. B Y Ulkü,
  6. Y Tüzün,
  7. S Serdaroğlu,
  8. E Altuğ,
  9. H Bahçecioğlu and
  10. G Güngen


    Eleven separate three-month courses of cyclosporin A, an oral solution 10 mg/kg/day, were administered to eight patients with Behçet's disease with sight-threatening posterior uveitis. It was found to be effective in arresting the inflammatory activity in the eye as well as the mucocutaneous lesions of Behçet's disease. Improvement in visual acuity was observed within one week of starting therapy. Severe exacerbations in the ocular and mucocutaneous lesions occurred on withdrawal of the drug. At this dosage side effects included hirsutism in all women, and a slight rise of serum bilirubins in two patients and of blood urea in one patient. The latter two conditions responded rapidly to dose adjustment.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.